• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Usher syndrome type-1G protein (USH1G)

ACP17421

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17421 Target NameUSH1G
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-461Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ495M9
Background Information
  • Uniprot Id

    Q495M9

  • Target Species

    Human

  • Target Name

    USH1G

  • Target Full Name

    pre-mRNA splicing regulator USH1G

  • Target Function

    Required for normal development and maintenance of cochlear hair cell bundles. Anchoring/scaffolding protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal hearing.

  • Target Involvement

    Usher syndrome 1G (USH1G)

  • Target Subcellular Location

    Cytoplasm, cytosol. Cytoplasm, cytoskeleton. Cell membrane; Peripheral membrane protein.

  • Target Tissue Specificity

    Expressed in vestibule of the inner ear, eye and small intestine.

  • Target Synonyms

    ANKS 4A; ANKS4A; FLJ33924; SANS; Scaffold protein containing ankyrin repeats and SAM domain; USH 1G; USH1G; USH1G_HUMAN; Usher syndrome 1G (autosomal recessive); Usher syndrome type 1G protein; Usher syndrome type-1G protein

Inquire Recombinant Human Usher syndrome type-1G protein (USH1G) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification